Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT03746002
Eligibility Criteria:
Inclusion Criteria:
* Admission within 48 hours for acute decompensated heart failure with at least one symptom and one sign of volume overload
* Receipt of loop diuretic prior to admission
* Plan to administer furosemide 120 - 160 mg IV bolus twice daily over the next 24 hours with additional diuresis deemed necessary
* If patient is concurrently administered intravenous vasodilator or inotrope, the dose of vasodilator or inotrope must be stable for 6 hours prior to enrollment with a plan to continue the same dose for the 24 hour duration of this study
Exclusion Criteria:
* Metolazone prescribed prior to admission
* Receipt of continuous intravenous infusion of furosemide
* Cirrhosis or end stage renal disease
* Non-English speaking patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT03746002
Study Brief:
Protocol Section:
NCT03746002